(August 31, 2017, 12:50 PM EDT) -- LOS ANGELES — A federal judge in California on Aug. 29 approved a $2.75 million settlement between Cigna Health and Life Insurance Co. and a class that claimed that the insurer improperly classified transcranial magnetic stimulation (TMS) as an experimental treatment for depression in an effort to avoid covering the procedure (Annette Weil, et al. v. Cigna Health and Life Insurance Co., et al., No. 15-07074, C.D. Calif., 2017 U.S. Dist. LEXIS 139093)....